ES2038621T3 - Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales. - Google Patents
Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales.Info
- Publication number
- ES2038621T3 ES2038621T3 ES198787109415T ES87109415T ES2038621T3 ES 2038621 T3 ES2038621 T3 ES 2038621T3 ES 198787109415 T ES198787109415 T ES 198787109415T ES 87109415 T ES87109415 T ES 87109415T ES 2038621 T3 ES2038621 T3 ES 2038621T3
- Authority
- ES
- Spain
- Prior art keywords
- antitumoral
- medicines
- factor
- preparation
- protection against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002270 gangliosides Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002887 neurotoxic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8648203A IT1208751B (it) | 1986-06-30 | 1986-06-30 | Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2038621T3 true ES2038621T3 (es) | 1993-08-01 |
Family
ID=11265194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787109415T Expired - Lifetime ES2038621T3 (es) | 1986-06-30 | 1987-06-30 | Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales. |
Country Status (16)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254280B (it) * | 1992-03-13 | 1995-09-14 | Fidia Spa | Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson |
| US6765087B1 (en) * | 1992-08-21 | 2004-07-20 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| DE4430041A1 (de) † | 1994-08-24 | 1996-02-29 | Milupa Ag | Allergieprotektive Formelnahrung |
| US5567684A (en) * | 1994-09-14 | 1996-10-22 | The Regents Of The University Of California | Synthetic ganglioside derivatives |
| WO2003017949A2 (en) | 2001-08-29 | 2003-03-06 | Neose Technologies, Inc. | Novel synthetic ganglioside derivatives and compositions thereof |
| JP2006519878A (ja) | 2003-03-06 | 2006-08-31 | ネオーズ テクノロジーズ， インコーポレイテッド | ガングリオシドの酵素合成のための方法および化合物 |
| CN102046151A (zh) * | 2008-03-26 | 2011-05-04 | 牛津大学 | 靶向内质网的脂质体 |
| EP2410846B1 (en) | 2009-03-25 | 2016-09-07 | Seneb Biosciences, Inc. | Glycolipids as treatment for disease |
| WO2011027344A2 (en) * | 2009-09-01 | 2011-03-10 | Hadasit Medical Research Services And Development Ltd. | Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1168205B (it) * | 1983-07-21 | 1987-05-20 | Wellcome Italia | Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione |
| IT1182209B (it) * | 1985-02-18 | 1987-09-30 | Fidia Farmaceutici | Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali |
-
1986
- 1986-06-30 IT IT8648203A patent/IT1208751B/it active
-
1987
- 1987-06-22 IL IL82944A patent/IL82944A/xx unknown
- 1987-06-25 GR GR871005A patent/GR871005B/el unknown
- 1987-06-25 FR FR878708937A patent/FR2601248B1/fr not_active Expired
- 1987-06-25 US US07/066,248 patent/US5229373A/en not_active Expired - Fee Related
- 1987-06-25 LU LU86930A patent/LU86930A1/fr unknown
- 1987-06-25 ZA ZA874597A patent/ZA874597B/xx unknown
- 1987-06-26 BE BE8700719A patent/BE1000723A4/fr not_active IP Right Cessation
- 1987-06-29 CA CA000540885A patent/CA1314219C/en not_active Expired - Fee Related
- 1987-06-29 DK DK333787A patent/DK165621C/da not_active IP Right Cessation
- 1987-06-29 AU AU74908/87A patent/AU601988B2/en not_active Ceased
- 1987-06-30 ES ES198787109415T patent/ES2038621T3/es not_active Expired - Lifetime
- 1987-06-30 JP JP62165131A patent/JPS6327434A/ja active Pending
- 1987-06-30 AT AT87109415T patent/ATE69381T1/de active
- 1987-06-30 EP EP87109415A patent/EP0251298B1/en not_active Expired - Lifetime
- 1987-06-30 DE DE19873721562 patent/DE3721562A1/de not_active Withdrawn
- 1987-06-30 DE DE8787109415T patent/DE3774501D1/de not_active Expired - Lifetime
-
1992
- 1992-02-12 GR GR910402224T patent/GR3003790T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK165621C (da) | 1993-06-01 |
| BE1000723A4 (fr) | 1989-03-21 |
| LU86930A1 (fr) | 1987-11-11 |
| DK333787A (da) | 1987-12-31 |
| GR871005B (en) | 1987-10-23 |
| EP0251298B1 (en) | 1991-11-13 |
| IT1208751B (it) | 1989-07-10 |
| GR3003790T3 (enrdf_load_stackoverflow) | 1993-03-16 |
| FR2601248A1 (fr) | 1988-01-15 |
| EP0251298A3 (en) | 1988-10-26 |
| FR2601248B1 (fr) | 1989-08-25 |
| IT8648203A0 (it) | 1986-06-30 |
| ZA874597B (en) | 1988-03-30 |
| DE3721562A1 (de) | 1988-03-03 |
| DE3774501D1 (de) | 1991-12-19 |
| AU7490887A (en) | 1988-01-07 |
| AU601988B2 (en) | 1990-09-27 |
| CA1314219C (en) | 1993-03-09 |
| EP0251298A2 (en) | 1988-01-07 |
| JPS6327434A (ja) | 1988-02-05 |
| IL82944A (en) | 1993-04-04 |
| DK165621B (da) | 1992-12-28 |
| US5229373A (en) | 1993-07-20 |
| DK333787D0 (da) | 1987-06-29 |
| ATE69381T1 (de) | 1991-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX171191B (es) | Composiciones farmaceuticas de glipizida | |
| MX9207382A (es) | Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene. | |
| ES2036553T3 (es) | Composiciones farmaceuticas que tienen actividad antineoplastica. | |
| AR012172A2 (es) | Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento | |
| PH24313A (en) | Emulsion composition for administration of sparingly water soluble ionizable hydrophobic drugs | |
| ES8105292A1 (es) | Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos | |
| AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
| AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
| AR004510A1 (es) | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento | |
| ES2090303T3 (es) | Uso de inositolfosfatos para preparar medicamentos. | |
| MX9306204A (es) | Derivados de acidos 25-carboxilico en la serie de la vitamina d, procedimiento para su preperacion, productos intermedios para ese procedimiento, preparados farmaceuticos que contegan esos derivados, asi como su uso para preparacion de medicamentos. | |
| MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
| ES2038621T3 (es) | Utilizacion de gangliosidos exogenos para la preparacion de un medicamento a utilizar en enfermedades tumorales como factor de proteccion contra la toxicidad por medicamentos antitumorales. | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| ES2108240T3 (es) | Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor. | |
| PT95697A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas | |
| ES2091183T3 (es) | Metodo para mejorar el sueño. | |
| ES2072416T3 (es) | Complejos de derivados de neolignano con fosfolipidos, su uso y formulaciones farmaceuticas y cosmeticas que los contienen. | |
| DE3675977D1 (de) | Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebs-chemotherapie und erhoehung der immunitaet. | |
| AR008858A1 (es) | Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas. | |
| FR2427328A1 (fr) | Ethers diphenyliques et medicament contenant ces substances | |
| NO920255L (no) | Podofyllotoksinpreparat som inneholder triglyserider | |
| YU107692A (sh) | Sulfonamidi i postupak za njihovo dobijanje | |
| IT8448710A1 (it) | Riduzione degli effetti tossici causati da farmaci antrachinonici | |
| FR2381786A1 (fr) | Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 251298 Country of ref document: ES |